Home / Healthcare / Pharmaceutical / North America Cutaneous T-Cell Lymphoma (CTCL) Therapeutics Market
North America Cutaneous T-Cell Lymphoma (CTCL) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Histone Deacetylase (HDAC) Inhibitors, Monoclonal Antibody, Antineoplastic Agent, and Others), By Disease Type (Mycosis Fungoides (MF), Sezary Syndrome (SS), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecasts, 2021-2028
Report Format: PDF | Latest Update: Sep, 2022 | Published Date: Feb, 2022 | Report ID: FBI106325 | Status : PublishedSummary
TOC
Methodology
Market Segmentation
Infographics
- North America
- 2020
- 73